TRP-2 / gp100 DNA vaccine and PD-1 checkpoint blockade combination for the treatment of intracranial tumors
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
TRP-2 / gp100 DNA vaccine and PD-1 checkpoint blockade combination for the treatment of intracranial tumors ; volume:73 ; number:9 ; day:2 ; month:7 ; year:2024 ; pages:1-13 ; date:9.2024
Cancer immunology immunotherapy ; 73, Heft 9 (2.7.2024), 1-13, 9.2024
- Urheber
-
Pearson, Joshua R. D.
Puig-Saenz, Carles
Thomas, Jubini E.
Hardowar, Lydia D.
Ahmad, Murrium
Wainwright, Louise C.
McVicar, Adam M.
Brentville, Victoria A.
Tinsley, Chris J.
Pockley, Alan Graham
Durrant, Lindy G.
McArdle, Stephanie E. B.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00262-024-03770-x
- URN
-
urn:nbn:de:101:1-2410310827143.829750240113
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pearson, Joshua R. D.
- Puig-Saenz, Carles
- Thomas, Jubini E.
- Hardowar, Lydia D.
- Ahmad, Murrium
- Wainwright, Louise C.
- McVicar, Adam M.
- Brentville, Victoria A.
- Tinsley, Chris J.
- Pockley, Alan Graham
- Durrant, Lindy G.
- McArdle, Stephanie E. B.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma
Bioinformatic analysis of PD-1 checkpoint blockade response in influenza infection
Strategies for sensitizing tumors to Anti-PD-1 immune checkpoint blockade
PD-1/PD-L1 immune checkpoint blockade in breast cancer: research insights and sensitization strategies
Optochemical Control of Immune Checkpoint Blockade via Light‐Triggered PD‐L1 Dimerization
Optochemical Control of Immune Checkpoint Blockade via Light‐Triggered PD‐L1 Dimerization
Cerebral vasculitis mimicking intracranial metastatic progression of lung cancer during PD-1 blockade
Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy
Adeno-associated virus delivered CXCL9 sensitizes glioblastoma to anti-PD-1 immune checkpoint blockade
PD-1/PD-L1 checkpoint blockade harnesses monocyte-derived macrophages to combat cognitive impairment in a tauopathy mouse model
Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade
Niclosamide, an antihelmintic drug, enhances efficacy of PD-1/PD-L1 immune checkpoint blockade in non-small cell lung cancer
Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma
Bioinformatic analysis of PD-1 checkpoint blockade response in influenza infection
Strategies for sensitizing tumors to Anti-PD-1 immune checkpoint blockade
PD-1/PD-L1 immune checkpoint blockade in breast cancer: research insights and sensitization strategies
Optochemical Control of Immune Checkpoint Blockade via Light‐Triggered PD‐L1 Dimerization
Optochemical Control of Immune Checkpoint Blockade via Light‐Triggered PD‐L1 Dimerization
Cerebral vasculitis mimicking intracranial metastatic progression of lung cancer during PD-1 blockade
Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy
Adeno-associated virus delivered CXCL9 sensitizes glioblastoma to anti-PD-1 immune checkpoint blockade
PD-1/PD-L1 checkpoint blockade harnesses monocyte-derived macrophages to combat cognitive impairment in a tauopathy mouse model
Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade
Niclosamide, an antihelmintic drug, enhances efficacy of PD-1/PD-L1 immune checkpoint blockade in non-small cell lung cancer
Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma
Bioinformatic analysis of PD-1 checkpoint blockade response in influenza infection
Strategies for sensitizing tumors to Anti-PD-1 immune checkpoint blockade
PD-1/PD-L1 immune checkpoint blockade in breast cancer: research insights and sensitization strategies
Optochemical Control of Immune Checkpoint Blockade via Light‐Triggered PD‐L1 Dimerization
Optochemical Control of Immune Checkpoint Blockade via Light‐Triggered PD‐L1 Dimerization
Cerebral vasculitis mimicking intracranial metastatic progression of lung cancer during PD-1 blockade
Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy
Adeno-associated virus delivered CXCL9 sensitizes glioblastoma to anti-PD-1 immune checkpoint blockade
PD-1/PD-L1 checkpoint blockade harnesses monocyte-derived macrophages to combat cognitive impairment in a tauopathy mouse model
Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade